je.st
news
Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA
2016-01-17 19:50:21| Biotech - Topix.net
Novartis announced today that the US Food and Drug Administration has approved Cosentyx for two new indications - the treatment of adult patients with active ankylosing spondylitis and active psoriatic arthritis . AS and PsA are both life-long, painful and debilitating inflammatory diseases that affect the joints and/or spine.
Tags: with
treatment
adult
approval
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||